149 related articles for article (PubMed ID: 38626012)
1. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
Chavez-Tapia NC; Sanchez-Jimenez BA; Vidaña-Perez D; Corrales-Rosas B; Balderas-Garces B; Vera-Izaguirre D; Santa Cruz FJ; Maldonado-Garcia C; Juarez-Hernandez E; Uribe M
PLoS One; 2024; 19(4):e0290632. PubMed ID: 38626012
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
3. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
[TBL] [Abstract][Full Text] [Related]
4. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
Boursier J; Hagström H; Ekstedt M; Moreau C; Bonacci M; Cure S; Ampuero J; Nasr P; Tallab L; Canivet CM; Kechagias S; Sánchez Y; Dincuff E; Lucena A; Roux M; Riou J; Trylesinski A; Romero-Gomez M
J Hepatol; 2022 May; 76(5):1013-1020. PubMed ID: 35063601
[TBL] [Abstract][Full Text] [Related]
7. Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study.
van der Voort EA; Koehler EM; Nijsten T; Stricker BH; Hofman A; Janssen HL; Schouten JN; Wakkee M
Acta Derm Venereol; 2016 Feb; 96(2):213-7. PubMed ID: 26062958
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
Prasetya IB; Hasan I; Wisnu W; Rumende CM
Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.
Kositamongkol C; Charernboon T; Chaisathaphol T; Washirasaksiri C; Auesomwang C; Sitasuwan T; Charatcharoenwitthaya P; Phisalprapa P
Medicine (Baltimore); 2021 Nov; 100(44):e27640. PubMed ID: 34871234
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
12. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
13. Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study.
Mikolasevic I; Domislovic V; Turk Wensveen T; Delija B; Klapan M; Juric T; Lukic A; Mijic A; Skenderevic N; Puz P; Ostojic A; Krznaric Z; Radic-Kristo D; Filipec Kanizaj T; Stimac D
Eur J Intern Med; 2020 Dec; 82():68-75. PubMed ID: 32839076
[TBL] [Abstract][Full Text] [Related]
14. Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.
Luo J; Du Z; Liang D; Li M; Yin Y; Chen M; Yang L
J Clin Lab Anal; 2022 Aug; 36(8):e24596. PubMed ID: 35808928
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.
Abeysekera KWM; Fernandes GS; Hammerton G; Portal AJ; Gordon FH; Heron J; Hickman M
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):295-305. PubMed ID: 31954687
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
18. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
[TBL] [Abstract][Full Text] [Related]
19. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
[TBL] [Abstract][Full Text] [Related]
20. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.
Kalaiyarasi K; Sanchalika A; Hsien Min L; Wei Ming Y; Vishalkumar S; Kuo Chao Y; Jee Keem L; Sameer J; Terence HCW; Yen Ping T
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
